Oncology & Cancer
Improved chemokine homing enhances CAR T–cell therapy for osteosarcoma
Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient's immune cells to target cancer cells. While successful in some types of leukemia, the approach has yet to realize its potential against pediatric ...
Aug 5, 2024
0
0